NMOSD Part 2 - The importance and tools for monitoring NMOSD -

Name: NMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity
Uploaded: 2024-02-15T00:00:00+00:00
Duration: 22 min 53 s
Description: In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOS

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
MS & Immune Disorders
Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
Sarah Conway, MD; Kristin Galetta, MD, MSeD
Sarah Conway, MD; Kristin Galetta, MD, MSeD
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Alzheimer Disease & Dementias
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
MS & Immune Disorders
Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
Jeffrey Dunn, MD
Jeffrey Dunn, MD
Paraclinical Optic Nerve Tests in Multiple Sclerosis
Paraclinical Optic Nerve Tests in Multiple Sclerosis
MS & Immune Disorders
Paraclinical Optic Nerve Tests in Multiple Sclerosis
Gregory P. Van Stavern, MD
Gregory P. Van Stavern, MD